Signature Estate & Investment Advisors LLC grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 14.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,633 shares of the medical research company’s stock after purchasing an additional 1,333 shares during the quarter. Signature Estate & Investment Advisors LLC’s holdings in Agilent Technologies were worth $683,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Jennison Associates LLC purchased a new stake in shares of Agilent Technologies during the 2nd quarter valued at $212,000. Commerce Bank purchased a new stake in Agilent Technologies in the 2nd quarter worth about $1,242,000. Delta Lloyd Asset Management N.V. purchased a new stake in Agilent Technologies in the 2nd quarter worth about $2,026,000. Prudential Financial Inc. increased its holdings in Agilent Technologies by 2.5% in the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock worth $27,134,000 after acquiring an additional 11,020 shares during the last quarter. Finally, Cipher Capital LP increased its holdings in Agilent Technologies by 18.1% in the 2nd quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after acquiring an additional 13,703 shares during the last quarter.
ILLEGAL ACTIVITY WARNING: “Agilent Technologies, Inc. (A) Shares Bought by Signature Estate & Investment Advisors LLC” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://transcriptdaily.com/2017/11/14/agilent-technologies-inc-a-shares-bought-by-signature-estate-investment-advisors-llc.html.
In related news, Director Boon Hwee Koh sold 4,500 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $63.63, for a total transaction of $286,335.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $63.26, for a total value of $316,300.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 165,720 shares of company stock valued at $10,488,739.
A has been the subject of several recent research reports. Jefferies Group LLC reissued a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 9th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price objective for the company in a report on Tuesday, October 31st. Robert W. Baird reissued a “buy” rating and issued a $70.00 price objective on shares of Agilent Technologies in a report on Friday, October 20th. Barclays PLC reissued a “buy” rating and issued a $67.00 price objective on shares of Agilent Technologies in a report on Wednesday, July 19th. Finally, Janney Montgomery Scott lifted their price objective on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Agilent Technologies presently has an average rating of “Buy” and a consensus price target of $66.70.
Shares of Agilent Technologies, Inc. (NYSE A) traded up $0.32 on Tuesday, hitting $67.13. The stock had a trading volume of 1,536,300 shares, compared to its average volume of 1,820,754. The company has a market cap of $21,600.00, a P/E ratio of 29.17, a PEG ratio of 2.62 and a beta of 1.28. The company has a current ratio of 3.22, a quick ratio of 2.76 and a debt-to-equity ratio of 0.39. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $68.67.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the company posted $0.49 EPS. equities research analysts expect that Agilent Technologies, Inc. will post 2.32 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 25th. Stockholders of record on Tuesday, October 3rd were given a dividend of $0.132 per share. The ex-dividend date of this dividend was Monday, October 2nd. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.79%. Agilent Technologies’s dividend payout ratio (DPR) is presently 27.32%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.